Fusion Family Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-210
Closed -$24K 201
2018
Q4
$24K Buy
210
+1
+0.5% +$112 0.01% 147
2018
Q3
$22K Buy
209
+1
+0.5% +$100 0.01% 163
2018
Q2
$18K Buy
208
+1
+0.5% +$82 0.01% 191
2018
Q1
$16K Sell
207
-198
-49% -$15.9K 0.01% 183
2017
Q4
$34K Buy
405
+205
+103% +$17.4K 0.01% 151
2017
Q3
$17K Sell
200
-3
-1% -$246 0.01% 134
2017
Q2
$17K Buy
203
+2
+1% +$163 0.01% 178
2017
Q1
$17K Sell
201
-43
-18% -$3.44K 0.01% 178
2016
Q4
$18K Buy
+244
New +$18.2K 0.01% 194

Other funds holding LLY

Fusion Family Wealth's LLY Position: Q1 2019 in Review

Fusion Family Wealth sold out of Eli Lilly (LLY) in Q1 2019, closing a stake of 210 shares — an estimated $24K sold.

Fusion Family Wealth first reported a position in LLY in Q4 2016 and held it in 9 quarters. The position peaked at $34K in Q4 2017. 1,604 funds tracked by Wall St. Rank hold LLY as of Q1 2019.

  • Fusion Family Wealth reported no remaining Eli Lilly position as of Q1 2019 after selling out during the quarter.
  • Fusion Family Wealth sold 210 Eli Lilly shares in Q1 2019, an estimated $24K.
  • Fusion Family Wealth first reported a position in Eli Lilly in Q4 2016 and held it in 9 quarters.
  • Fusion Family Wealth's Eli Lilly position peaked at $34K in Q4 2017.
  • 1,604 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2019.

Based on Fusion Family Wealth's 13F filing for Q1 2019, filed 10 May 2019.